Aspira Pathlab & Diagnostics Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 5.36 | 5.91 | 5.50 |
| Operating Expense | 4.43 | 4.72 | 4.64 |
| Net Profit | 0.47 | 0.72 | 0.38 |
| Net Profit Margin | 8.77 | 12.18 | 6.91 |
| Earning Per Share | 0.46 | 0.70 | 0.37 |
| EBIDTA | 0.93 | 1.18 | 0.86 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 5.36 |
| Operating Expense | 4.43 |
| Net Profit | 0.47 |
| Net Profit Margin | 8.77 |
| Earning Per Share | 0.46 |
| EBIDTA | 0.93 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 22.00 | 13.20 | 14.46 |
| Operating Expenses Annual | 18.47 | 14.39 | 12.86 |
| Operating Profit Annual | 3.91 | -0.77 | 1.91 |
| Interest Annual | 0.35 | 0.37 | 0.42 |
| Depreciation | 1.49 | 1.51 | 1.53 |
| Net Profit Annual | 2.07 | -2.67 | -0.09 |
| Tax Annual | TBA | TBA | TBA |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 22.00 |
| Operating Expenses Annual | 18.47 |
| Operating Profit Annual | 3.91 |
| Interest Annual | 0.35 |
| Depreciation | 1.49 |
| Net Profit Annual | 2.07 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.80 | 0.57 | 1.35 |
| Cash Flow from Operations | 1.88 | 1.05 | -0.01 |
| Cash Flow from Investing | 0.07 | 0.14 | 0.16 |
| Cash Flow from Financing | -0.99 | -0.95 | -0.94 |
| Cash Flow at the End | 1.75 | 0.80 | 0.57 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.80 |
| Cash Flow from Operations | 1.88 |
| Cash Flow from Investing | 0.07 |
| Cash Flow from Financing | -0.99 |
| Cash Flow at the End | 1.75 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 17.82 | -5.76 | 13.28 |
| PBIT Margin (%) | 11.05 | -17.42 | 2.28 |
| PBT Margin (%) | -20.36 | 29.70 | -3.18 |
| Net PROFIT Margin (%) | 9.41 | -20.23 | -0.62 |
| Return On Networth / Equity (%) | 16.88 | TBA | TBA |
| Return On Networth /Employed (%) | 11.71 | TBA | TBA |
| Return On Assets (%) | 14.11 | -18.00 | -0.54 |
| Total Debt / Equity (X) | 0.15 | 0.16 | 0.20 |
| Asset Turnover Ratio (%) | 1.50 | 0.89 | 0.87 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 17.82 |
| PBIT Margin (%) | 11.05 |
| PBT Margin (%) | -20.36 |
| Net PROFIT Margin (%) | 9.41 |
| Return On Networth / Equity (%) | 16.88 |
| Return On Networth /Employed (%) | 11.71 |
| Return On Assets (%) | 14.11 |
| Total Debt / Equity (X) | 0.15 |
| Asset Turnover Ratio (%) | 1.50 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 6.53 | 6.79 | 8.01 |
| Total Current Assets Annual | 5.36 | 4.36 | 5.86 |
| Non Current Assets Annual | 12.15 | 10.35 | 11.49 |
| Total Shareholders Funds Annual | 12.22 | 10.14 | 12.75 |
| Total Assets Annual | 17.51 | 14.71 | 17.34 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 6.53 |
| Total Current Assets Annual | 5.36 |
| Non Current Assets Annual | 12.15 |
| Total Shareholders Funds Annual | 12.22 |
| Total Assets Annual | 17.51 |
EPS (INR)
Expected
0.41
Reported
0.41
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
